Insights into the Management of Overactive Bladder: What Difference Can Mirabegron Make?

Journal Title: Journal of Urological Surgery - Year 2019, Vol 6, Issue 2

Abstract

Oral pharmacotherapy constitutes second-line treatment for overactive bladder (OAB) after lifestyle modifications, bladder retraining, and pelvic floor muscle exercises. Antimuscarinics have an established role in the treatment of OAB. However, antimuscarinics are known to have low persistence rates in clinical practice. Mirabegron is an oral β3-adrenoreceptor agonist which has emerged as an alternative to antimuscarinics for managing OAB. Overall, mirabegron has similar clinical efficacy to antimuscarinics and is superior to placebo. Mirabegron has been generally well tolerated in both interventional and non-interventional studies. Persistence has been shown to be higher with mirabegron than with antimuscarinics in realworld studies. Increased blood pressure is associated with mirabegron and therefore its use is contraindicated in patients with severe uncontrolled hypertension. However, a low rate of treatment cessation due to cardiovascular issues has been noted in clinical trials. Mirabegron’s utility in the elderly patient population has been well supported with promising efficacy and safety outcomes. New data from a prospective placebo-controlled randomized trial in older OAB patients is expected to be published soon. Mirabegron does not interfere with detrusor contractions during the emptying phase of the micturition cycle and hence lacks any significant effect on post-void residual volume. Mirabegron can be combined with antimuscarinics to synergize clinical effectiveness. Overall, mirabegron represents a well-tolerated and effective medical treatment option for OAB. Mirabegron could be used as an alternative to antimuscarinics, especially in patients who do not improve with antimuscarinics and/or experience bothersome side effects for whom anticholinergic load may be a relevant consideration.

Authors and Affiliations

Ömer Acar, Mustafa Levent Erton, Tufan Tarcan

Keywords

Related Articles

Effect of Mirabegron on Intraocular Pressure in Patients with Glaucoma

Objective: Assessment of the effects of mirabegron treatment used for overactive bladder (OAB) symptoms in glaucoma patients on intraocular structures. Materials and Methods: One hundred-twenty six female glaucoma patie...

Bacterial Colonization of Ureteral Double-J Stents in Patients with Negative Urine Culture

Objective: Ureteral double-J stents are extensively used in urology practice. We aimed to investigate the bacterial colonization rate and predominant microorganisms on ureteral double-J stents in patients with negative u...

An Unusual Cause of Chronic Scrotal Pain Coexisting with Hydrocele: Isolated Tuberculous Epididymitis

Isolated tuberculous epididymitis (ITE) is a rare condition affecting only the epididymis without clinical evidence of renal involvement. One of the causes of chronic scrotal pain can be ITE, which is usually only diagno...

Evaluation of Short-term Postoperative Complications According to the Clavien-Dindo Classification System in Thermocautery-assisted Circumcision Cases

Objective: Circumcision is one of the most performed surgical procedures in the world. This study is a retrospective study on the short-term postoperative complications after a thermocautery-assisted circumcision on a se...

Significance of Core Length in Current Transrectal Ultrasound-guided Prostate Biopsy in Patients with Normal Digital Rectal Examination

Objective: To reveal the significance of core length in current primary transrectal ultrasound-guided prostate biopsy (TRUS-PB) in patients with normal digital rectal examination. Materials and Methods: Data of 3520 pat...

Download PDF file
  • EP ID EP48971
  • DOI 10.4274/jus.galenos.2019.2533
  • Views 322
  • Downloads 0

How To Cite

Ömer Acar, Mustafa Levent Erton, Tufan Tarcan (2019). Insights into the Management of Overactive Bladder: What Difference Can Mirabegron Make?. Journal of Urological Surgery, 6(2), -. https://europub.co.uk/articles/-A-48971